Activatable near-infrared emission-guided on-demand administration of photodynamic anticancer therapy with a theranostic nanoprobe
Citations Over TimeTop 10% of 2019 papers
Abstract
Development of theranostic probes that can be used to identify tumors and direct the on-demand drug administration to cancers is ongoing but remains challenging. Herein, we report a theranostic platform composed of a H2S-activated imaging probe and a light-sensitive drug. The designed probe affords advantages of H2S-activated NIR emission light-up and efficient 1O2 generation, enabling the selective visualization of H2S-rich cancers and the subsequent imaging-directed on-demand light exposure to the detected cancers while leaving normal tissues untouched. Such controllable administration of photodynamic anticancer therapy maximizes the therapeutic efficiency and minimizes side effects. This work should facilitate significant advances toward precise diagnosis and treatment of cancer.
Related Papers
- → Recent advances of sonodynamic therapy in cancer treatment(2016)293 cited
- → Newly developed strategies for improving sonodynamic therapy(2020)266 cited
- → Antitumor Effect of Photodynamic Therapy/Sonodynamic Therapy/Sono-Photodynamic Therapy of Chlorin e6 and Other Applications(2023)111 cited
- → Development of porphyrin and titanium dioxide sonosensitizers for sonodynamic cancer therapy.(2021)9 cited
- → Nanostructured and molecular ROS generators for Photo- and Sonodynamic therapy(2022)